Omeros Corporation
USPTO PatentsView assignee record - 71 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Omeros ranks #4,905 of 49,997 tracked US assignees by granted-patent volume, with 71 patents across 21 technology areas.
- #4,905
- of 49,997 US assignees by volume
- Top 13%
- by Innovation Score (50.6/100)
- 16.0
- avg claims per patent
- -14%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R4905 · US Corporation #4,905 · 71 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 71 grants
- TOP-DECILE #4,905/49,997
- PHOTO-FINISH National University…
- CPC-FOCUS A61P · 21 areas
- INNOV-PAR 50.6/100
- CLAIMS-RICH 16.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -14% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: National University OF Defense Technology (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Omeros’s 50.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Omeros
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- ION Geophysical · near
ION Geophysical · near
51 score
- Everdisplay… · near
Everdisplay… · near
51 score
- Mirka · near
Mirka · near
51 score
- Omeros · this assignee
Omeros · this assignee
51 score
- Shanghai Biren… · near
Shanghai Biren… · near
51 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Omeros's Innovation Score is 50.6/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Omeros?
Each dot is one of Omeros’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Omeros’s own 16.0 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Omeros's grants concentrate
Omeros Corporation is a focused PatentsView assignee: 21 CPC subclasses with 84.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (11 grants) versus a trough of 3 in 2019. By volume, Omeros sits between National University OF Defense Technology and Pukyong National University Industry-University Cooperation Foundation.
Omeros's three-year grant acceleration
Omeros Corporation shows 21 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Omeros's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- National Universi…
National University OF Defense Technology
71 patents
- NGM Biopharmaceut…
NGM Biopharmaceuticals, Inc.
71 patents
- Nuvera Fuel Cells
Nuvera Fuel Cells, LLC
71 patents
- Ohio State Univer…
Ohio State University
71 patents
- PME IP PTY
PME IP PTY Ltd
71 patents
- Pro-iroda Industr…
Pro-iroda Industries, Inc.
71 patents
- Proxense
Proxense, LLC
71 patents
- Pukyong National…
Pukyong National University Industry-University Cooperation Foundation
71 patents
- Omeros ◀
Omeros Corporation
71 patents
What this shows Omeros holds 71 patents at rank #4,905, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Omeros
By rank, the assignees closest to #4,905 in granted patent volume.
- National University OF Defense Technology #4,901 · 71 patents
- NGM Biopharmaceuticals, Inc. #4,902 · 71 patents
- Nuvera Fuel Cells, LLC #4,903 · 71 patents
- Ohio State University #4,904 · 71 patents
- PME IP PTY Ltd #4,906 · 71 patents
- Pro-iroda Industries, Inc. #4,907 · 71 patents
- Proxense, LLC #4,908 · 71 patents
- Pukyong National University Industry-University Cooperation Foundation #4,909 · 71 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Omeros's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Omeros, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Omeros ranks #287 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (51 here).
Similar claim depth
Nearest assignees by average claims per patent (16.0 here).
Omeros's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 13% higher than 87% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 9 | 12.7% |
| 2016 | 9 | 12.7% |
| 2017 | 9 | 12.7% |
| 2018 | 7 | 9.9% |
| 2019 | 3 | 4.2% |
| 2020 | 6 | 8.5% |
| 2021 | 5 | 7.0% |
| 2022 | 5 | 7.0% |
| 2023 | 5 | 7.0% |
| 2024 | 11 | 15.5% |
| 2025partial year | 2 | 2.8% |
Which technologies does Omeros Corporation patent most?
Top 15 of 21 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Omeros Corporation's patent record in context - here's where to go next.
- Omeros Corporation's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 84.5% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #4,905 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Omeros Corporation against National University OF Defense Technology, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 50.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.